<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="33634">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02128919</url>
  </required_header>
  <id_info>
    <org_study_id>309320</org_study_id>
    <nct_id>NCT02128919</nct_id>
  </id_info>
  <brief_title>Transcranial Direct Current Stimulation (tDCS) As A Treatment For Cigarette Craving and Cognitive Deficits in Schizophrenic</brief_title>
  <acronym>TDCSSCHIZ</acronym>
  <official_title>Transcranial Direct Current Stimulation (tDCS) As A Treatment For Cigarette Craving and Cognitive Deficits in Schizophrenic</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nathan Kline Institute for Psychiatric Research</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nathan Kline Institute for Psychiatric Research</source>
  <oversight_info>
    <authority>United States: Nathan Kline  Institute for Psychiatric Research IRB</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a study of the effects of tDCS on smoking , craving for cigarettes, cognition, and
      psychiatric symptoms in schizophrenic  patients who are current smokers or have a  history
      of regular cigarette smoking. It assesses smoking with CO mentoring, nicotine and cotinine
      levels, and  craving with QSU scale and response to craving slides. Cognition is measures by
      MATRICS  battery, symptoms are measured by PANSS scale and hallucination scale.

      This is double-blind sham-controlled study, with active  tDCS 2ma or 20 minutes over 5 days,
      and sham tDCS for 40 seconds on each  sham occasion.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2012</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Cigarette Craving</measure>
    <time_frame>change from basleine in craving after 5 tdcs sessions</time_frame>
    <safety_issue>No</safety_issue>
    <description>QSU carving scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cognitive Improvment</measure>
    <time_frame>change from baseline in craving after 5 tdcs sessions</time_frame>
    <safety_issue>No</safety_issue>
    <description>MATRICS battery composite and domain scores at baseline and one day after completion of 5 tDCS sessions</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Psychiatric symptoms</measure>
    <time_frame>change from baseline after 5 tdcs sessions</time_frame>
    <safety_issue>No</safety_issue>
    <description>PANSS total score and positive and negative symptom score.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Schizophrenia</condition>
  <condition>Cognition</condition>
  <condition>Cigarette Smoking</condition>
  <arm_group>
    <arm_group_label>Active tDCS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>tDCS 2ma for 20 min with anode at DLPFC once a day   for 5 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham tDCS</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>tDCS 2 ma for 40 second s with anode at DLPFC for 5 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>tDCS</intervention_name>
    <description>Transcranial Direct Current Stimulation</description>
    <arm_group_label>Active tDCS</arm_group_label>
    <arm_group_label>Sham tDCS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of schizophrenia spectrum disorder History of cigarette smoking

        Exclusion Criteria:

          -  Seizure disorder or current treated neurological illness Current Acute exacerbation
             of psychotic state
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Nathan Kline insgtitute for Psychiatric Research</name>
      <address>
        <city>Orangeburg</city>
        <state>New York</state>
        <zip>10962</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Senale Mattiuz, MD</last_name>
      <phone>845-398-5474</phone>
      <email>smattiuz@nki.rfmh.org</email>
    </contact>
    <investigator>
      <last_name>Robert C Smith, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 29, 2014</lastchanged_date>
  <firstreceived_date>April 26, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Nathan Kline Institute for Psychiatric Research</investigator_affiliation>
    <investigator_full_name>Robert C. Smith MD PhD</investigator_full_name>
    <investigator_title>Research Psychiatrist</investigator_title>
  </responsible_party>
  <keyword>Schizophrenia</keyword>
  <keyword>Cigarette smoking</keyword>
  <keyword>Cognition</keyword>
  <keyword>Craving</keyword>
  <keyword>MATRICS</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Schizophrenia</mesh_term>
    <mesh_term>Smoking</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
